Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease

Whitney W. Stevens*, Anna G. Staudacher, Kathryn E Hulse, Roderick G. Carter, Deborah R. Winter, Atsushi Kato, Lydia Suh, James E. Norton, Julia H. Huang, Anju T. Peters, Leslie C. Grammer, Caroline P.E. Price, David B. Conley, Stephanie Shintani Smith, Bruce K. Tan, Kevin C. Welch, Robert C. Kern, Robert P. Schleimer

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Background: Aspirin-exacerbated respiratory disease (AERD) is characterized by asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and an intolerance of medications that inhibit cyclooxygenase-1. Patients with AERD have more severe upper and lower respiratory tract disease than do aspirin-tolerant patients with CRSwNP. A dysregulation in arachidonic acid metabolism is thought to contribute to the enhanced sinonasal inflammation in AERD. Objective: Our aim was to utilize an unbiased approach investigating arachidonic acid metabolic pathways in AERD. Methods: Single-cell RNA sequencing (10× Genomics, Pleasanton, Calif) was utilized to compare the transcriptional profile of nasal polyp (NP) cells from patients with AERD and patients with CRSwNP and map differences in the expression of select genes among identified cell types. Findings were confirmed by traditional real-time PCR. Lipid mediators in sinonasal tissue were measured by mass spectrometry. Localization of various proteins within NPs was assessed by immunofluorescence. Results: The gene encoding for 15-lipooxygenase (15-LO), ALOX15, was significantly elevated in NPs of patients with AERD compared to NPs of patients with CRSwNP (P < .05) or controls (P < .001). ALOX15 was predominantly expressed by epithelial cells. Expression levels significantly correlated with radiographic sinus disease severity (r = 0.56; P < .001) and were associated with asthma. The level of 15-oxo-eicosatetraenoic acid (15-Oxo-ETE), a downstream product of 15-LO, was significantly elevated in NPs from patients with CRSwNP (27.93 pg/mg of tissue) and NPs from patients with AERD (61.03 pg/mg of tissue) compared to inferior turbinate tissue from controls (7.17 pg/mg of tissue [P < .001]). Hydroxyprostaglandin dehydrogenase, an enzyme required for 15-Oxo-ETE synthesis, was predominantly expressed in mast cells and localized near 15-LO+ epithelium in NPs from patients with AERD. Conclusions: Epithelial and mast cell interactions, leading to the synthesis of 15-Oxo-ETE, may contribute to the dysregulation of arachidonic acid metabolism via the 15-LO pathway and to the enhanced sinonasal disease severity observed in AERD.

Original languageEnglish (US)
JournalJournal of Allergy and Clinical Immunology
DOIs
StateAccepted/In press - Jan 1 2020

Keywords

  • 15-lipoxygenase
  • 15-oxo-eicosatetraenoic acid
  • AERD
  • ALOX15
  • aspirin-exacerbated respiratory disease
  • Chronic sinusitis
  • CRSwNP
  • hydroxyprostaglandin dehydrogenase
  • nasal polyps

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease'. Together they form a unique fingerprint.

  • Cite this